BSECompany Update▲ PositiveResults4 Aug 2026
Morepen Laboratories Ltd
Please find attached the Q1 FY 27 Investor Presentation
Morepen Laboratories Ltd has released its Q1 FY 27 Investor Presentation, highlighting a 34% YoY increase in revenue, 207% YoY increase in EBITDA, and 394% YoY increase in PAT. The company attributes this performance to operational execution and commercial validation of its Morepen 2.0 strategy.
BSEBoard Meeting▲ PositiveResults4 Aug 2026
Dr. Agarwals Health Care Ltd
Outcome of the Meeting of the Board of Directors of the Company held on August 04, 2026, is attached.
Dr. Agarwal's Health Care Ltd has announced its unaudited consolidated financial results for Q1 FY2027, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores. The company has also announced the appointment of new auditors, internal auditors, and cost auditors, and the incorporation of a wholly owned subsidiary in Nigeria.
NSEPress Release▲ PositiveResults4 Aug 2026
Indian Metals & Ferro Alloys Limited
Press Release
Indian Metals & Ferro Alloys Ltd (IMFA) has announced its Q1 FY2027 earnings, reporting a record revenue of ₹960.45 crore, up 50% from ₹641.54 crore in Q1 FY26, driven by higher ferro chrome output and firm prices. The company's EBITDA and PAT also saw significant increases, to ₹281.27 crore and ₹191.49 crore, respectively. IMFA's Greenfield Expansion Project at Kalinganagar (KNR 1) is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. The company has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, which will contribute to its green footprint.
NSEPress Release▲ PositiveResults4 Aug 2026
Capillary Technologies India Limited
Press Release
Capillary Technologies India Limited has announced its financial results for the first quarter ended June 30, 2026, with a 43% year-on-year growth in operating revenue and a 132% year-on-year growth in adjusted EBITDA. The company reported strong profitability metrics with normalized profit after tax (PAT) growing exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.
BSECompany Update▲ PositiveResults4 Aug 2026
Capillary Technologies India Ltd
Press release on Q1 Financial results
Capillary Technologies India Ltd reported strong revenue growth of 43% year-on-year for the quarter ended June 30, 2026, driven by healthy expansion within the existing customer base, growth in new annual contract value contributions and the addition of SessionM. Adjusted EBITDA of ₹ 440.2 Million for the quarter ended June 30, 2026 registered a year-on-year growth of 132%. Normalized Profit after tax of ₹ 254.4 Million for the quarter ended June 30, 2026 also grew exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.
BSECompany Update▲ PositiveResults4 Aug 2026
Indian Metals & Ferro Alloys Ltd
As per corporate Announcement Attached
Indian Metals & Ferro Alloys Ltd reported record revenue and robust financial performance in Q1 FY27, driven by higher volumes and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, and it has signed a long-term offtake arrangement for additional 65 MWp hybrid renewable energy.
BSECompany Update▲ PositiveResults4 Aug 2026
Trualt Bioenergy Ltd
Please find attached the Intimation
TruAlt Bioenergy Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a revenue of close to INR630 crores and a PAT of close to INR4.5 crores. The company has also announced plans to increase its capacity utilization by another 20% to 25% and has secured viability gap funding of INR150 crores from the Government of India.
BSECompany Update▲ PositiveResults4 Aug 2026
Supreme Petrochem Ltd
Transcript of Earnings Conference Call held on July 29, 2026 is enclosed herewith.
Supreme Petrochem Ltd reported Q1 FY27 earnings, with revenue from operations at INR 1693 crores, a 22% YoY growth. EBITDA stood at INR 331 crores, with a strong growth of 188% YoY, and net profit after tax was at INR 236 crores.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults4 Aug 2026
TruAlt Bioenergy Limited
Analysts/Institutional Investor Meet/Con. Call Updates
TruAlt Bioenergy Limited has informed the Exchange about the transcript of Earnings Conference Call held on July 29, 2026, to discuss the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
NSERecord Date▲ PositiveResults4 Aug 2026
RITES Limited
Record Date
RITES Limited has informed the Exchange that Record date for the purpose of first interim Dividend for the FY 2026-27 is 10-Aug-2026. The company has declared an interim dividend of ₹ 1.40 per share (14% of paid-up share capital) for the financial year 2026-27. The Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on 30th June, 2026, along with Limited Review Reports thereon are enclosed herewith.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults4 Aug 2026
Supreme Petrochem Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Supreme Petrochem Limited has announced its Q1 FY27 earnings, with revenue from operations at INR 1693 crores, a 22% year-on-year growth, driven by a significant increase in raw material prices due to conflict in West Asia. The company's operating EBITDA stood at INR 331 crores, with a strong growth of 188% year-on-year, and net profit after tax was at INR 236 crores.
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026
RITES Limited
Outcome of Board Meeting
RITES Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a profit of ₹71.80 crore and an EPS of ₹1.49. The company has also declared a 1st Interim Dividend of ₹1.40 per share (14% of paid-up share capital) for the Financial Year 2026-27.
BSECompany Update▲ PositiveResults4 Aug 2026
Mankind Pharma Ltd
Please find attached transcript of the Investor Conference call for Q1FY27 held on July 30, 2026
Mankind Pharma Ltd's Q1FY27 earnings conference call transcript is available on the company's website, with overall revenue increasing to INR4,031 crores, up 13% year-on-year, and EBITDA margin improving by 250 bps year-on-year to 26.3%.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults4 Aug 2026
Mankind Pharma Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Mankind Pharma Limited's Q1 FY27 earnings conference call transcript is available on their website, with key highlights including a 13% year-on-year revenue growth to INR4,031 crores, EBITDA of INR1,060 crores, and an EBITDA margin improvement of 250 bps to 26.3%. The company also reported a 12.7% growth in secondary sales as per IQVIA, driven by healthy volume growth of 4.7% and strong momentum in chronic and BSV specialty business.
BSEResult▲ PositiveResults4 Aug 2026
Styrenix Performance Materials Ltd
Unaudited Standalone and Consolidated Financial Results for first Quarter ended on June 30, 2026 and Declaration of Interim Dividend Rs. 23 per equity share.
Styrenix Performance Materials Ltd has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, with a net profit of INR 137.32 crores and an earnings per share of INR 78.09. The company has also declared an interim dividend of Rs. 23 per equity share.
BSECompany Update▲ PositiveResults4 Aug 2026
Keystone Realtors Ltd
Press Release for the unaudited financial result (consolidated and standalone) for the quarter ended June 30, 2026
Keystone Realtors Ltd announced its unaudited financial results for Q1FY27, with a 72% revenue growth, highest-ever Q1 profit after tax (PAT) with 221% YoY PAT growth, and EBITDA margin expanding to 21.3%. The company recorded pre-sales of INR 6.17 bn, collections of INR 5.99 bn, and operating cash flows of INR 0.68 bn. Keystone Realtors added 2 new projects with an estimated GDV of INR 5.47 bn and has a strong launch pipeline with an estimated GDV of INR 80 bn planned across the MMR over the coming quarters.
BSECompany Update▲ PositiveResults4 Aug 2026
United Foodbrands Ltd
Earnings Presentation on quarterly financial results of the Company for the quarter ended June 30, 2026
United Foodbrands Ltd reported strong Q1 FY27 results with 43.4% YoY revenue growth, driven by 63.5% YoY dine-in volume growth and 61.9% YoY delivery revenue growth. The company added 5 new restaurants in Q1 FY27, taking its total network to 266 restaurants, and is on track to reach 300+ restaurants by FY27 and 400-425 by FY30.
NSEInvestor Presentation▲ PositiveResults4 Aug 2026
United Foodbrands Limited
Investor Presentation
United Foodbrands Limited has informed the Exchange about Investor Presentation, with Q1 FY27 revenue of ₹ 4,259 million; Y-o-Y growth of 43.4%, driven by strong dine-in volumes and delivery revenue growth.
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026
Styrenix Performance Materials Limited
Outcome of Board Meeting
Styrenix Performance Materials Limited has submitted its unaudited standalone and consolidated financial results for the period ended June 30, 2026, along with the declaration of an interim dividend. The company's revenue from operations for the quarter ended June 30, 2026, was ₹76.804 crore, with a net profit of ₹13.732 crore.
NSECopy of Newspaper Publication▲ PositiveResults4 Aug 2026
Gulf Oil Lubricants India Limited
Copy of Newspaper Publication
Gulf Oil Lubricants India Limited has published its unaudited financial results for the first quarter ended June 30, 2026, showing a revenue growth of 32.52% and a PAT growth of 31.93% year-over-year. The company's revenue from operations increased to ₹1,32,035.99 lakhs, with a net profit from ordinary activities after tax and exceptional items of ₹12,752.45 lakhs.